RxDoctor Payments Data

Jefferson Boulet, PA

Medical · Buckley, WANPI 1740274745

Payments from drug & device makers

$1,199in general payments, 2019–2025

Across 66 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$491
  • Otsuka America Pharmaceutical, Inc.$185
  • Astellas Pharma US Inc$108
  • Lilly USA, LLC$63
  • Takeda Pharmaceuticals U.S.A., Inc.$39
  • Phathom Pharmaceuticals, Inc.$34
  • plus $280 from 12 others

What the payments were for

  • Food & beverage$1,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,199 in reported general payments places this provider in the 75th percentile of 457 medical providers in Washington.

See all medical providers in Washington

Medicare billing

Part B allowed, 2024
$60,420
Medicare patients
154
Services billed
1,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$69,234
JardianceEmpagliflozin50$48,847
EliquisApixaban55$38,485
XareltoRivaroxaban40$35,947
FarxigaDapagliflozin Propanediol11$14,242
Spiriva HandihalerTiotropium Bromide19$13,645
Spiriva RespimatTiotropium Bromide15$12,231
SymbicortBudesonide/Formoterol Fumarate26$9,126
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$7,578
Humalog Kwikpen U-100Insulin Lispro14$7,512
PremarinEstrogens, Conjugated22$5,698
Gabapentin194$3,650
ButransBuprenorphine12$3,636
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$3,362
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen178$3,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$21$69,23456 claims
Boehringer IngelheimJardiance, Spiriva Respimat$15$61,07865 claims
AstraZenecaFarxiga, Symbicort$21$23,36937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 457 medical providers in Washington.

Other medical in Buckley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →